Brief: Epigenomics Q1 net loss shrinks to EUR 2.4 mln

Epigenomics AG

10/05/2017 07:00

May 10 (Reuters) - EPIGENOMICS AG  ECXn.DE : 
    * Q1 TOTAL REVENUE SLIGHTLY DECREASED TO EUR 281 THOUSAND (Q1 2016: EUR 295 THOUSAND) MAINLY 
DUE TO TERMINATION OF A LICENSING AGREEMENT FOR SALE OF SAMPLE PREPARATION KITS 
    * OPERATING COSTS IN Q1 2017 DECREASED SIGNIFICANTLY TO EUR 3.1 MILLION (Q1 2016: EUR 5.3 
MILLION) 
    * OPERATING LOSS (EBIT) FOR Q1 2017 DECREASED TO EUR -2.7 MILLION (Q1 2016: EUR -4.6 
MILLION) 
    * NET LOSS FOR Q1 2017 DECREASED TO EUR -2.4 MILLION (Q1 2016: EUR -4.3 MILLION) 
    * COMPANY'S LIQUIDITY (CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES) AT REPORTING DATE 
WAS EUR 10.7 MILLION (DEC 31, 2016: EUR 12.3 MILLION) 
    * COMPANY CONFIRMS OUTLOOK FOR FINANCIAL YEAR 2017 AS PROVIDED ON APRIL 26, 2017. 
 
Source text for Eikon:  ID:nEQ35JwLc  
Further company coverage:  ECXn.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))